Adagene Is A Globalclinical Stage Immunotherapy Company Listed On Nasdaqdedicated To Advancing Antibody Based Cancer Treatmentsthe Company Focuses On Innovative Approaches To Immunotherapyaiming To Meet Unmet Patient Needs Through Its Advanced Technologies And Strategic Collaborations Central To Adagene S Work Is Its Dynamic Precision Librarydplplatformwhich Includes Three Key Technologiesneobodya C For Novel Antibody Discoverysafebody For Enhancing Safety And Targeting Specific Tumorsand Powerbodya C To Increase Antibody Potencythe Lead Clinical Programadg126Muzastotug Is A Masked Anti Ctla 4 Safebody Antibody Currently In Phase 1B 2 Studies For Treating Metastatic Microsatellite Stable Colorectal Cancer In Combination With Anti Pd 1 Therapy Adagene Combines Computational Biology And Artificial Intelligence In Its Antibody Design Process And Has Formed Strategic Partnerships With Global Organizations To Enhance The Safety And Efficacy Of Its Therapiesthe Company Is Committed To Transparency And Regularly Shares Updates On Its Financial Performance And Clinical Advancements
